To ensure efficient production and compliance with all regulatory requirements, our Dehradun plants are equipped with the latest technology
Plant 1
First Plant of Windlas Group established in Year 2001, recommissioned to Nutraceuticals in 2020. Approved from Food Safety and Standards Authority of India (FSSAI), and ISO 22000: 2018; catering Domestic & ROW Markets. Tablets, Capsules, Syrups, and Sachets are the available dosage forms.
Plant 2
Largest Volume Plant of the Group having Tablets, Capsules, Syrups, and Sachets dosage forms; catering Domestic & ROW Markets. Approved from WHO GMP, FDA-Philippines, NDA-Uganda, TMDA-Tanzania, PPB-Kenya, MOH-Cambodia, and others.
Plant 3
WHO GMP Certified Plant having Tablets and Capsules dosage forms. It's a Small-scale Plant manufacturing drug products for Domestic market only.
Plant 4
Windlas Biotech Ltd. Plant-4, formerly known as Windlas Healthcare Pvt. Ltd. is approved from WHO-GMP, EU-GMP, South African Health Products Regulatory Authority (SAHPRA), and FDA Philippines. This Plant also deals with Tablets, Capsules, and Sachets dosage forms however caters Regulatory markets like Europe, Canada and South-Africa alongwith Domestic Indian market. Ecovadis & Sedex Assessed Company
Plant 5
The newly commissioned Plant and the first Injection facility of the Windlas Group designed for Small Volume Parenteral (SVP). Approved from WHO-GMP and comply with all international CGMP norms and EU, PDA, ISO, and PIC/S Standards. Facility is equipped with dedicated manufacturing lines for different sizes Ampoules, Vials and Lyophilized Vials.
